Macquarie’s Bastard Child, page-3

I understand the emotion with this investment and I would say everyone has a different level of angst, dependant on where they entered.

But this company still deserves a price at their revenue, product offering, and sticky client base - particularly within a global environment of compounding data growth……and on consumption licences.

Does anyone else see this?……

So it's going to be hard to feel like you are purchasing a ‘slam dunk certainty now’ with the red flags in play …..but with the incoming of new management, a proven product, and more investment R&D and sales - I’d argue there is risk reward here….and with all the negative sentiment - perhaps a lower price will be on offer - but who has a crystal ball for that.